Dendrite Appoints Carl L. Cohen as President of Marketing Solutions.

BEDMINSTER, N.J. -- Dendrite International, Inc. (NASDAQ:DRTE) a leading provider of pharmaceutical industry solutions, today announced the appointment of Carl L. Cohen as President of its Marketing Solutions division. Mr. Cohen is an integral addition to Dendrite's new management team and will be responsible for driving this rapidly growing division.

Mr. Cohen joins Dendrite from Starwood Hotels and Resorts Worldwide, one of the largest hotel chains in the world, where he most recently served as Senior Vice President. Mr. Cohen held several strategic positions during his tenure at Starwood, including running its software and services division and starting a profitable broadband business unit. He also led many crucial initiatives, notably the creation of a new reservation and loyalty marketing system for the hotel chain.

Previously, Mr. Cohen served as Chief Marketing Officer at Wrenchhead.com and Executive Vice President of Marketing for Championship Auto Racing Teams, a global brand in auto sports. During his career, Mr. Cohen has held several senior marketing and brand management leadership positions at companies such as Philip Morris, Colgate Palmolive and Reckitt & Coleman.

"Based on the products and services available today and those coming in the future, the Marketing Solutions division at Dendrite is poised for explosive growth on a global scale," said Mr. Cohen. "The opportunity to join Dendrite at this exciting time, to help lead this innovative division, was one that I could not resist."

"Carl will bring a fresh perspective to Dendrite from a successful career that has spanned more than 20 years in a wide range of industries," said Joseph Ripp, president and COO of Dendrite. "We're looking forward to Carl's contributions, including spearheading the kind of new thinking and approaches that will be instrumental to Dendrite as we continue to forge a leadership path."

Mr. Cohen is a graduate of SUNY at Albany and earned his Master's of Business Administration from The Wharton School of the University of Pennsylvania.

About Dendrite

Founded in 1986, Dendrite International (NASDAQ: DRTE) enables sales, marketing, clinical and compliance solutions for the global pharmaceutical industry. The Company's clients are located in more than 50 countries and include the world's top 20 pharmaceutical companies. For more information, please visit www.dendrite.com.

Note: Dendrite is a registered trademark of Dendrite International, Inc.

This document may contain forward-looking statements that may be identified by such forward-looking terminology as "expect," "believe," "anticipate," "will," "intend," "plan," "target," "outlook," "guidance," and similar statements or variations. Such forward-looking statements are based on our current expectations, estimates, assumptions and projections and involve significant risks and uncertainties, including risks which may result from our dependence on the pharmaceutical industry; fluctuations in quarterly revenues due to lengthy sales and implementation cycles for certain of our solutions; our fixed expenses in relation to fluctuating revenues and variations in customers' budget cycles; dependence on certain major customers; changes in demand for our products and services attributable to any weakness experienced in the economy or mergers, acquisitions and consolidations in the pharmaceutical industry; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; international operations; integrating the entities we acquire; our ability to effectively manage our growth; the protection of our proprietary technology; our ability to compete in the Internet-related products and services market; the continued demand for Internet-related products and services; the ability of our third party vendors to respond to technological change; our ability to maintain our relationships with third-party vendors; less favorable than anticipated results from strategic relationships; dependence of data solutions on strategic relationships; events which may affect the U.S. and world economies; and catastrophic events which could negatively affect our information technology infrastructure. Other important factors that should be reviewed and carefully considered are included in the company's 10-K, 10-Qs, and other reports filed with the SEC. Actual results may differ materially. The company assumes no obligation for updating any such forward-looking statements to reflect actual results, changes in assumptions or other changes affecting such forward-looking statements.